CN Search Menu
Keep improving Xinbo safety review
Quality First Accurate Service
Service innovation Pharmaceutical research Benefit human health

  • Keep improving Xinbo safety review

    To build a well-known CRO enterprise that is first-class in China and in line with international standards
    Online
    Online
    More

  • Quality First Accurate Service

    Professional provision of preclinical drug safety evaluation services
    Online
    Online
    More

  • Service innovation Pharmaceutical research Benefit human health

    A national high-tech enterprise specialized in providing preclinical safety evaluation services of drugs
    Online
    Online
    More

Service Ability

Early drug forming screening

Non clinical study of drugs

Biological evaluation of medical devices

Laboratory Services

More

News Update

Officially implemented on May 1st: Detailed Rules for Order No. 818 | Notice of the National Health Commission on the Issuance of Work Standards for the Approval of Clinical Translation and Applicatio

...

2026/05/01

...

2026/04/30

World Laboratory Animal Day | Spring light reflects on the silent guardians of life

...

2026/04/27

Drug Regulatory Information | Announcement of the National Medical Products Administration on the Issuance of Work Procedures for the Review and Approval of Conditional Marketing Applications for Drug

...

2026/04/27

Pharmaceutical Regulatory News | CDE Revised and Issued the "Drug Development and Technical Review Communication Management Measures of the National Medical Products Administration's Center for Drug E

...

2026/04/10

Shandong Xinbo helps Class 1.1 pediatric fever patch get approved for clinical trials

According to the official website of the Center for Drug Evaluation of the National Medical Products Administration and public information, Shandong Xinbo Pharmaceutical Research Co., Ltd. (hereinafter referred to as "Shandong Xinbo") assisted the Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, in obtaining implied approval for the clinical trial of a new drug, "Magui Antipyretic Patch" (acceptance number: CXZL2500136)....

2026/03/27

Shandong Xinbo sincerely invites you to attend the 9th China International Forum on Antibody Drug Development and Vaccine Innovation in 2026

On April 2-3, 2026, the "CVAIF 2026 - 9th International Forum on Antibody Drug Development and Vaccine Innovation in China", sponsored by the Organizing Committee of the China Vaccine and Antibody Drug Innovation International Forum and the Biopharmaceutical Division of AVIC Huanyu, will be grandly held at Fengda International Hotel in Yizhuang, Beijing....

2026/03/18

"She" shines with her own light | Shandong Xinbo pays tribute to every remarkable woman

In March, the spring breeze brings warmth, and Women's Day arrives as scheduled. Around us, there is such a group of lovely people. They are the resilient roses in the workplace, working diligently, making the most of their time, and writing the responsibility of Xinbo people with their perseverance...

2026/03/07

Celebrate Yuanxiao | Shandong Xinbo wishes you a happy Yuanxiao Festival and family reunion!

Celebrate Yuanxiao | Shandong Xinbo wishes you a happy Yuanxiao Festival and family reunion!...

2026/03/03

Academic News | CDE Releases "Reference Preparation Catalogue for Chemical Generic Drugs (104th Batch)" (Draft for Comments)

...

2026/03/03

More

您是否找到了需要的信息？

太好了，感谢您提供反馈。
感谢您提供反馈。